topotecan has been researched along with fluorodeoxyglucose f18 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Havlioglu, N; Hueser, CN; Nguyen, NC; Osman, M; Patel, AJ | 1 |
| Alvarez Secord, A; Case, AS; Cohn, DE; Dehdashti, F; Eisenhauer, EL; Gao, F; Lippmann, LT; Massad, LS; Mutch, DG; Powell, MA; Rader, JS; Thaker, PH; Valea, FA; Wright, JD; Zighelboim, I | 1 |
1 trial(s) available for topotecan and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Topotecan; Uterine Cervical Neoplasms; Young Adult | 2013 |
1 other study(ies) available for topotecan and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Extrapulmonary small cell carcinoma: involvement of the brain without evidence of extracranial malignancy by serial PET/CT scans.
Topics: Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Craniotomy; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Topotecan | 2008 |